Abivax ADR (NASDAQ:ABVX)’s traded shares stood at 0.5 million during the last session, with the company’s beta value hitting 0.04. At the close of trading, the stock’s price was $6.98, to imply a decrease of -0.57% or -$0.04 in intraday trading. The ABVX share’s 52-week high remains $14.22, putting it -103.72% down since that peak but still an impressive 31.66% since price per share fell to its 52-week low of $4.77.
Analysts have given a consensus recommendation of Buy for Abivax ADR (ABVX), translating to a mean rating of 1.17. Of 1 analyst(s) looking at the stock, 0 analyst(s) give ABVX a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 1 recommend it as a Buy.
Abivax ADR (NASDAQ:ABVX) trade information
After registering a -0.57% downside in the last session, Abivax ADR (ABVX) has traded red over the past five days. The 5-day price performance for the stock is -14.77%, and 14.43% over 30 days. With these gigs, the year-to-date price performance is -4.64%.
The extremes give us $12 and $12 for target low and target high price respectively. As such, ABVX has been trading -71.92% off suggested target high and -71.92% from its likely low.
An assessment of the company’s 5-year growth patterns shows that annual earnings shrunk an estimated -1.44% for the past 5-year period. While 2025 is set for a 1.21% return in earnings, projections for the next 5 years are at 10.70% annually.
ABVX Dividends
Abivax ADR has its next earnings report out in July. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
The next major institution holding the largest number of shares is DEEP TRACK CAPITAL, LP with 4.18 million shares, or about 9.7055% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $55.26 million.
We also have abrdn World Healthcare Fund and Franklin Strategic Series-FRANKLIN BIOTECHNOLOGY DISCOVERY FUND as the top two Mutual Funds with the largest holdings of the Abivax ADR (ABVX) shares. Going by data provided on Mar 31, 2025 , abrdn World Healthcare Fund holds roughly 710.52 shares. This is just over 1.12% of the total shares, with a market valuation of $4.96 million. Data from the same date shows that the other fund manager holds a little less at 497.69, or 0.78% of the shares, all valued at about 3.47 million.
